Finance

Lists
CGNX:NASDAQ
Cognex Corp
USD 62,20
+2,31%
(+1,40) 1D
4 Sep., 14:43:50 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CGNX...
Open
USD 60,96
High
USD 62,43
Low
USD 60,79
Mkt. cap
10,46 mjd
Avg. vol.
2,12 m
Volume
547,03 k
Dividend
0,55%
Quarterly dividend
USD 0,09
Ex-dividend date
20 Aug. 2026
P/E ratio
60,22
52-wk high
USD 72,88
52-wk low
USD 34,61
EPS
USD 1,03
Beta
1,49
Shares outstanding
168,22 m
No. of employees
3 k
Open
USD 60,96
High
USD 62,43
Low
USD 60,79
Mkt. cap
10,46 mjd
Avg. vol.
2,12 m
Volume
547,03 k
Dividend
0,55%
Quarterly dividend
USD 0,09
Ex-dividend date
20 Aug. 2026
P/E ratio
60,22
52-wk high
USD 72,88
52-wk low
USD 34,61
EPS
USD 1,03
Beta
1,49
Shares outstanding
168,22 m
No. of employees
3 k
News stories
From web sources and news partners
Profile
Cognex Corporation is an American manufacturer of machine vision systems, software and sensors used in automated manufacturing to inspect and identify parts, detect defects, verify product assembly, and guide assembly robots. Cognex is headquartered in Natick, Massachusetts, USA and has offices in more than 20 countries. Cognex began exploring commercial applications of machine vision in the early 1980s. In the 1990s, Cognex's business grew due to a demand for machine vision tools to help automate semiconductor and electronics manufacturing. While semiconductor manufacturing remains an important market for Cognex, it has expanded to general manufacturing applications. The company's product portfolio includes In-Sight, VisionPro software, and DataMan. Wikipedia
About Cognex Corp
CEORobert J. Willett
Employees2,74 k
Founded1981
HeadquartersNatick, Massachusetts, Verenigde State van Amerika
Sector-
Websitecognex.com
Analyst ratings
Based on 13 analysts giving stock ratings to CGNX in the past 3 months
Buy
Buy
8
Hold
5
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for CGNX in the last 3 months.
Highest
Current USD 62,20
USD 91,00 (+46,31%)
Average
USD 77,67 (+24,88%)
Lowest
USD 65,00 (+4,51%)
Analyst
Recommendation
Action
Price target
Projected
Date
Tomohiko Sano
J.P. Morgan
Buy
Maintained
USD 75,00
+20,6%
08/21/2026
Jamie Cook
Truist Financial
Hold
Maintained
USD 78,00
+25,4%
08/11/2026
Matt Summerville
D.A. Davidson
Hold
Maintained
USD 65,00
+4,5%
08/10/2026
Helen Fang
HSBC
Hold
Downgraded
USD 65,00
+4,5%
08/10/2026
Guy Hardwick
Barclays
Buy
Maintained
USD 80,00
+28,6%
08/10/2026
Troy Jensen
Cantor Fitzgerald
Buy
Reiterated
USD 84,00
+35,1%
08/06/2026
James Ricchiuti
Needham
Buy
Reiterated
USD 80,00
+28,6%
08/07/2026
Quinn Fredrickson
Robert W. Baird
Hold
Reiterated
-
-
08/07/2026
Piyush Avasthy
Citi
Hold
Maintained
USD 74,00
+19%
08/07/2026
Kenneth Newman
KeyBanc
Buy
Reiterated
USD 80,00
+28,6%
08/07/2026
Joseph C Giordano
TD Cowen
Buy
Reiterated
USD 85,00
+36,7%
08/07/2026
Joe Ritchie
Goldman Sachs
Buy
Reiterated
USD 91,00
+46,3%
08/07/2026
Jay Huang
Bernstein
Buy
Reiterated
USD 75,00
+20,6%
07/20/2026
Robert Mason CFA
Robert W. Baird
Hold
Maintained
USD 72,00
+15,8%
05/08/2026
Amit Mehrotra
UBS
Buy
Maintained
USD 80,00
+28,6%
05/08/2026
Tommy Moll
Stephens
Buy
Maintained
USD 75,00
+20,6%
05/07/2026
Richard Eastman
Robert W. Baird
Hold
Maintained
USD 55,00
-11,6%
02/17/2026
Damian Karas
UBS
Buy
Maintained
USD 70,00
+12,5%
02/13/2026
Last report
06 Aug. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
USD 0,45 / USD 0,42
+5,93%beat
Revenue / Est. (USD)
291,26 m / 292,51 m
-0,43%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Apr. 2026
Jul. 2026
Revenue
276,89 m
252,34 m
268,44 m
291,26 m
Cost of goods sold
89,60 m
86,43 m
77,50 m
85,49 m
Cost of revenue
89,60 m
86,43 m
77,50 m
85,49 m
Research and development expenses
35,08 m
36,06 m
37,02 m
32,39 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
94,44 m
94,57 m
94,04 m
87,86 m
Operating expense
129,52 m
130,63 m
131,07 m
120,26 m
Total operating expenses
219,13 m
217,06 m
208,56 m
205,75 m
Operating income
57,76 m
35,28 m
59,87 m
85,52 m
Other non operating income
61,00 k
-7,00 k
-68,00 k
-446,00 k
EBT including unusual items
62,86 m
44,08 m
61,76 m
89,30 m
EBT excluding unusual items
62,86 m
39,03 m
63,30 m
89,30 m
Income tax expense
45,20 m
11,42 m
10,05 m
16,54 m
Effective tax rate
71,90%
25,90%
16,28%
18,53%
Other operating expenses
-
-
-
-
Net income
17,66 m
32,66 m
51,70 m
72,76 m
Net profit margin
6,38%
12,94%
19,26%
24,98%
Earnings per share
0,33
0,27
0,34
0,45
Interest and investment income
4,20 m
4,72 m
4,84 m
5,09 m
Interest expense
-
-
-
-
Net interest expenses
4,20 m
4,72 m
4,84 m
5,09 m
Depreciation and amortization charges
-
-
-
-
EBITDA
65,30 m
42,60 m
67,11 m
92,40 m
Gain or loss from assets sale
-
-4,90 m
1,54 m
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme